GoldenGolden
Advanced Search
Novo Seeds

Novo Seeds

Novo Seeds is a capital investment and private equity firm that is interested in biotechnology sectors that deliver healthcare applications

Novo Seeds is a capital investment and private equity firm that is interested in biotechnology sectors that deliver healthcare applications. The firm was founded in 2007, in Hallerup, Hovedstaden, Denmark.

The firm is interested in companies that develop drugs for illnesses, molecules that interact with disease-causing modalities, biotechnology, protein interactions, and proprietary platforms. The firm has made a total of nineteen investments, with notable exits including Galecto Biotech and Lysogene. The firm invests during Series B and venture rounds.

Timeline

January 6, 2021
Novo Seeds, announces that its portfolio company CorWave has raised EUR 35 million in a Series C financing.

Invested in

Funding Rounds Participated In

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Brandon May
July 9, 2021
BioSpace
The company launches with the new funding to advance its focus on first-in-class small molecule therapies for neurodegenerative diseases.
FinSMEs
July 9, 2021
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
Novo Seeds
June 2, 2021
www.prnewswire.com:443
/PRNewswire/ -- Tribune Therapeutics ("Tribune"), a company founded to exploit a novel, pan-antifibrotic mechanism across a wide range of indications,...
Novo Seeds
April 29, 2021
www.prnewswire.com:443
/PRNewswire/ -- Novo Seeds, the early stage investment and company creation team of Novo Holdings, announced today an investment in Adcendo, a Danish biotech...
Adcendo
April 29, 2021
www.prnewswire.com:443
/PRNewswire/ -- Adcendo, a biotech company developing antibody-drug conjugates (ADCs) for the treatment of cancers, today announced the successful closing of a...
SHOW MORE

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.